Literature DB >> 20133677

N-acetylserotonin activates TrkB receptor in a circadian rhythm.

Sung-Wuk Jang1, Xia Liu, Sompol Pradoldej, Gianluca Tosini, Qiang Chang, P Michael Iuvone, Keqiang Ye.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a cognate ligand for the TrkB receptor. BDNF and serotonin often function in a cooperative manner to regulate neuronal plasticity, neurogenesis, and neuronal survival. Here we show that NAS (N-acetylserotonin) swiftly activates TrkB in a circadian manner and exhibits antidepressant effect in a TrkB-dependent manner. NAS, a precursor of melatonin, is acetylated from serotonin by AANAT (arylalkylamine N-acetyltransferase). NAS rapidly activates TrkB, but not TrkA or TrkC, in a neurotrophin- and MT3 receptor-independent manner. Administration of NAS activates TrkB in BDNF knockout mice. Furthermore, NAS, but not melatonin, displays a robust antidepressant-like behavioral effect in a TrkB-dependent way. Endogenous TrkB is activated in wild-type C3H/f(+/+) mice but not in AANAT-mutated C57BL/6J mice, in a circadian rhythm; TrkB activation is high at night in the dark and low during the day. Hence, our findings support that NAS is more than a melatonin precursor, and that it can potently activate TrkB receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133677      PMCID: PMC2840510          DOI: 10.1073/pnas.0912531107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  36 in total

1.  The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.

Authors:  G F Oxenkrug; I M McIntyre; P J Requintina; J D Duffy
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1991       Impact factor: 5.067

2.  Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y.

Authors:  M Encinas; M Iglesias; N Llecha; J X Comella
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

3.  Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.

Authors:  M Rios; G Fan; C Fekete; J Kelly; B Bates; R Kuehn; R M Lechan; R Jaenisch
Journal:  Mol Endocrinol       Date:  2001-10

4.  Genetic differences in a tail suspension test for evaluating antidepressant activity.

Authors:  R Trullas; B Jackson; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  A chemical-genetic approach to studying neurotrophin signaling.

Authors:  Xi Chen; Haihong Ye; Rejji Kuruvilla; Narendrakumar Ramanan; Katherine W Scangos; Chao Zhang; Nicolas M Johnson; Pamela M England; Kevan M Shokat; David D Ginty
Journal:  Neuron       Date:  2005-04-07       Impact factor: 17.173

6.  Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness.

Authors:  C Kopp; E Vogel; M Rettori; P Delagrange; R Misslin
Journal:  Neuropharmacology       Date:  2000-07-24       Impact factor: 5.250

7.  Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination.

Authors:  Juan Carlos Arévalo; Janelle Waite; Rithwick Rajagopal; Mercedes Beyna; Zhe-Yu Chen; Francis S Lee; Moses V Chao
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

8.  Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant.

Authors:  A S Ivy; F G Rodriguez; C Garcia; M J Chen; A A Russo-Neustadt
Journal:  Pharmacol Biochem Behav       Date:  2003-04       Impact factor: 3.533

Review 9.  Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.

Authors:  Megan E Kozisek; David Middlemas; David B Bylund
Journal:  Pharmacol Ther       Date:  2007-08-15       Impact factor: 12.310

Review 10.  Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation.

Authors:  Surajit Ganguly; Steven L Coon; David C Klein
Journal:  Cell Tissue Res       Date:  2002-05-29       Impact factor: 5.249

View more
  68 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

2.  Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression.

Authors:  Yan-li Huang; Xue-bing Liang; Li-qi Qian; Chuan Cai; Jun Guo; Chao Gao; Jian-hua Guan; Guo-ping Zhao
Journal:  Chin J Integr Med       Date:  2014-08-26       Impact factor: 1.978

Review 3.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

4.  The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.

Authors:  Zoya Marinova; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-03-18       Impact factor: 3.575

5.  Circadian variations in behaviors, BDNF and cell proliferation in depressive mice.

Authors:  Li-Tao Yi; Liu Luo; Yong-Jing Wu; Bin-Bin Liu; Xiao-Long Liu; Di Geng; Qing Liu
Journal:  Metab Brain Dis       Date:  2015-07-18       Impact factor: 3.584

6.  Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.

Authors:  Giada Mondanelli; Alice Coletti; Francesco Antonio Greco; Maria Teresa Pallotta; Ciriana Orabona; Alberta Iacono; Maria Laura Belladonna; Elisa Albini; Eleonora Panfili; Francesca Fallarino; Marco Gargaro; Giorgia Manni; Davide Matino; Agostinho Carvalho; Cristina Cunha; Patricia Maciel; Massimiliano Di Filippo; Lorenzo Gaetani; Roberta Bianchi; Carmine Vacca; Ioana Maria Iamandii; Elisa Proietti; Francesca Boscia; Lucio Annunziato; Maikel Peppelenbosch; Paolo Puccetti; Paolo Calabresi; Antonio Macchiarulo; Laura Santambrogio; Claudia Volpi; Ursula Grohmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-05       Impact factor: 11.205

7.  N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury.

Authors:  Hua Zhou; Jian Wang; Jiying Jiang; Irina G Stavrovskaya; Mingchang Li; Wei Li; Qiaofeng Wu; Xinmu Zhang; Chengliang Luo; Shuanhu Zhou; Ana C Sirianni; Sovan Sarkar; Bruce S Kristal; Robert M Friedlander; Xin Wang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

8.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

Review 9.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.

Authors:  Bai Lu; Guhan Nagappan; Xiaoming Guan; Pradeep J Nathan; Paul Wren
Journal:  Nat Rev Neurosci       Date:  2013-05-15       Impact factor: 34.870

Review 10.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.